1. Pisters PWT, Kelsen DP, Tepper JE (2011) Cancer of the stomach. In: DeVita VT, Lawrence TS, Rosenberg SA (eds) DeVita, Hellman, and Rosenberg’s cancer: principles and practice of oncology, 8th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1043–1068
2. National Comprehensive Cancer Network (NCCN) Panel (2013) NCCN clinical practice guidelines in oncology: gastric cancer (including cancer in the proximal 5 cm of the stomach) version 2. http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf . Accessed 21 Sep 2013
3. Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK (2010) Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Ann Surg Oncol 17:1024–1032
4. Biffi R, Fazio N, Luca F, Chiappa A, Andreoni B, Zampino MG, Roth A, Schuller JC, Fiori G, Orsi F, Bonomo G, Crosta C, Huber O (2010) Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World J Gastroenterol 16:868–874
5. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Genève J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721